AnteoTech Progresses COVID-19 Test Toward Market Launch

AnteoTech Ltd (ASX: ADO) ("AnteoTech" or "the Company") is pleased to provide a brief update on the COVID-19 Antigen Rapid Test (ART)1 development program. Manufacturing Technology Transfer on Track Since signing a Memorandum of Understanding with Operon in Spain, announced to the market on 26 November 2020, AnteoTech has been working with the Operon team to facilitate the technology transfer that